Odyssey Therapeutics News

Odyssey Raises $304M in Upsized IPO

May 11, 2026

Odyssey Therapeutics raised $304M in an upsized Nasdaq IPO to fund OD-001, SLC15A4 and TNFR2 autoimmune pipeline programs.